Urs Wehinger - Cicor Technologies Sec
| CICN Stock | CHF 56.60 0.40 0.70% |
Insider
Urs Wehinger is Sec of Cicor Technologies
| Age | 78 |
| Phone | 41 71 913 73 00 |
| Web | https://www.cicor.com |
Cicor Technologies Management Efficiency
The company has return on total asset (ROA) of 0.0257 % which means that it generated a profit of $0.0257 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0341 %, meaning that it generated $0.0341 on every $100 dollars invested by stockholders. Cicor Technologies' management efficiency ratios could be used to measure how well Cicor Technologies manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Damian Heller | Basilea Pharmaceutica AG | 57 | |
| Lutz Wevelsiep | Basilea Pharmaceutica AG | N/A | |
| Philipp Frech | Evolva Holding SA | N/A | |
| Davide Malavasi | COSMO Pharmaceuticals SA | 50 | |
| FCMA CGMA | Santhera Pharmaceuticals Holdin | 60 | |
| Neville MD | Santhera Pharmaceuticals Holdin | N/A | |
| Carsten Daweritz | Evolva Holding SA | 50 | |
| Kaspar Mueller | Evolva Holding SA | 60 | |
| David Veitch | Basilea Pharmaceutica AG | 58 | |
| Luigi Longo | COSMO Pharmaceuticals SA | 44 | |
| Gerrit Hauck | Basilea Pharmaceutica AG | 59 | |
| Marc Schrader | Santhera Pharmaceuticals Holdin | N/A | |
| Thomas CFA | Evolva Holding SA | N/A | |
| Oliver Strub | Santhera Pharmaceuticals Holdin | 60 | |
| Marco Lecchi | COSMO Pharmaceuticals SA | 59 | |
| Marc MD | Basilea Pharmaceutica AG | 59 | |
| Christian Wichert | Evolva Holding SA | N/A | |
| Gnther Metz | Santhera Pharmaceuticals Holdin | 65 | |
| Thomas Meier | Santhera Pharmaceuticals Holdin | 61 | |
| Dario Eklund | Santhera Pharmaceuticals Holdin | 55 | |
| Laurenz Kellenberger | Basilea Pharmaceutica AG | 56 | |
Management Performance
| Return On Equity | 0.0341 | |||
| Return On Asset | 0.0257 |
Cicor Technologies Leadership Team
Elected by the shareholders, the Cicor Technologies' board of directors comprises two types of representatives: Cicor Technologies inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cicor. The board's role is to monitor Cicor Technologies' management team and ensure that shareholders' interests are well served. Cicor Technologies' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cicor Technologies' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Marco Kechele, Ex Operations | ||
| Urs Wehinger, Sec | ||
| Peter Neumann, CFO Board | ||
| Alexander Hagemann, Chief Officer |
Cicor Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Cicor Technologies a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0341 | |||
| Return On Asset | 0.0257 | |||
| Profit Margin | 0.01 % | |||
| Operating Margin | 0.04 % | |||
| Current Valuation | 214.14 M | |||
| Shares Outstanding | 3.41 M | |||
| Shares Owned By Insiders | 11.69 % | |||
| Shares Owned By Institutions | 41.17 % | |||
| Price To Earning | 39.33 X | |||
| Price To Book | 1.47 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Cicor Stock Analysis
When running Cicor Technologies' price analysis, check to measure Cicor Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cicor Technologies is operating at the current time. Most of Cicor Technologies' value examination focuses on studying past and present price action to predict the probability of Cicor Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cicor Technologies' price. Additionally, you may evaluate how the addition of Cicor Technologies to your portfolios can decrease your overall portfolio volatility.